NCT06212752 2025-11-12MK-3475A-D77Merck Sharp & Dohme LLCPhase 3 Active not recruiting39 enrolled 21 charts
NCT05722015 2025-09-11MK-3475A-D77Merck Sharp & Dohme LLCPhase 3 Active not recruiting377 enrolled 17 charts 1 FDA
NCT01938456 2014-07-28Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung CancerGlaxoSmithKlinePhase 1 Withdrawn